No immediate trading signal; monitor for future open-market activity or changes in fundamentals. These grants suggest retention or compensation alignment but no insider sentiment on valuation.
QURE drugs
QURE drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 2 $10.50entry
- T+1 · 9mo ago −14.00%α −13.09% · $9.03
- T+5 · 8mo ago +71.33%α +72.54% · $17.99
- T+20 · 8mo ago +40.29%α +48.22% · $14.73
- T+60 · 6mo ago +139.52%α +130.20% · $25.15
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Multiple C-suite executives at uniQure N.V. received non-cash stock awards totaling 0 shares at $0 value on 2026-03-04. These are routine equity grants with no open-market transaction or economic value transfer.
Key Financial Metrics
Key Facts
- All 10 transactions were non-cash grants (Form 4 code 'A') with $0 transaction value
- Grants issued to five C-suite executives including CEO, CFO, CMO, CLO, and Chief Customer & Strategy Officer
- No open-market purchases (P) or sales (S) occurred in the cluster
- Total dollar value of transactions is $0
Financial Impact
$0 in actual cash flow impact; equity grants may lead to future dilution but are standard compensation practice
Risk Factors
- Potential for future dilution from new share issuance
- Perception of excessive executive compensation if grant sizes are above peer norms
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (10 trades, 7d window) | cluster-QURE-1773104427957 |
Track record
38 reports on QURE
6 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +27.15% at T+20 after the Jul 29, 2026 report. 8 of 11 went positive at some point.
Filters
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $22.79 to $22.71 Now $21.88 −3.99% ▼ −0.35% +0.02% vs SPY
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 6/10 Entry $23.03 to $21.01 Now $21.88 −4.99% ▼ −8.77% −4.36% vs SPY
- Nov 2, 202614d ago 8-K Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
- Nov 2, 202614d ago Press Release Bullish 7/10 Entry $22.97 to $23.87 Now $21.88 −4.75% ▲ +3.92% +3.62% vs SPY
- Oct 16, 20264w ago SC 13G/A Neutral 3/10 Entry $21.78 to $22.20 Now $21.88 +0.46% ▲ +1.93% +1.51% vs SPY
- Sep 2, 202610w ago 8-K Bullish 7/10 Entry $46.23 to $44.86 Now $21.88 −52.67% ▼ −2.96% −4.01% vs SPY
- Jul 29, 202615w ago 8-K Bullish 8/10 Entry $40.07 to $42.19 Now $21.88 −45.40% ▲ +5.29% +3.61% vs SPY
- Jul 7, 202619w ago Insider Cluster Bearish 5/10 Entry $41.41 to $43.49 Now $21.88 +47.16% ▼ −5.02% −5.33% vs SPY
- Jul 2, 202619w ago Insider Cluster Bearish 4/10 Entry $41.81 to $41.36 Now $21.88 +47.67% ▲ +1.08% +1.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers